Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to ... FDA approval for Xarelto in the new indication is based on data from the phase 3 MAGELLAN trial, and is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback